Continuing Education credits for the National Rx Drug Abuse & Heroin Summit are jointly provided by Postgraduate Institute for Medicine (PIM), Vendome Healthcare Media and Operation UNITE.
Information on this page is current through March 22, 2018.
National Rx Drug Abuse & Heroin Summit Target Audience
This activity has been designed to meet the educational needs of physicians, pharmacists, dentists, advanced practice registered nurses, registered nurses, social workers, addiction professionals, prevention professionals, health education specialists, certified counselors, lawyers, law enforcement officials and psychologists.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Vendome Group. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AAFP and NAADAC are now available!
Physician Continuing Medical Education
The Postgraduate Institute of Medicine designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Family Physicians
This Live activity, National Rx Drug Abuse & Heroin Summit, with a beginning date of 04/02/2018, has been reviewed and is acceptable for up to 15.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 15.0 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined
Psychology Sponsors Approval
The Postgraduate Institute for Medicine (PIM) is approved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibility for this program and its content.
Credit Designation: This program offers 15.5 continuing education credits for psychologists.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 15.5 contact hour(s) (1.5 CEUs) of the Accreditation Council for Pharmacy Education.
Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required. Upon completing the evaluation on www.cmeuniversity.com, your transcript information will be sent to the NABP CPE Monitor Service.
The Georgia Peace Officer Standards and Training (POST) Council has approved Summit recognition for up to 13 training credit hours for Georgia peace officers that are required to be registered or certified by the Council. Course Title: 2018 National Rx Drug Abuse & Heroin Summit. Course Number: NXI00G.
NOTE: To claim these credit hours Georgia POST members MUST sign the attendance sheet in EACH session.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint sponsorship efforts between Postgraduate Institute for Medicine and Vendome Group. Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.
Postgraduate Institute for Medicine designates this activity for 15.5 continuing education credits.
Certified Counselor Credit
National Rx Drug Abuse & Heroin Summit has been approved by NBCC for NBCC Credit. Sessions approved for NBCC credit are clearly identified, Postgraduate Institute for Medicine is solely responsible for all aspects of the program. NBCC approval No. SP-3013.
Social Worker Credit Designation
This program was approved for 15.5 Related Hours of continuing education credit by the National Association of Social Workers-Georgia Chapter as authorized by Postgraduate Institute for Medicine.
An application has been submitted to NAADAC and is under review.
State Bar of Georgia
The Georgia Commission on Continuing Lawyer Competency has approved:
- Course ID: 235034
- Course Name: National Rx Drug Abuse & Heroin Summit
- Approved Hours: 15.5 Regular CLE Hours
NOTE: To claim these CLE hours Georgia Bar members MUST sign the attendance sheet in EACH session.
Health Educator Credit
Sponsored by Postgraduate Institute for Medicine, a designated a provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 13.5 total Category I continuing education contact hours. Maximum advanced-level continuing education contact hours available are 13.5.
CME Planning Committee
The Rx Summit CME Planning Committee is comprised of National Advisory Board members Daniel Blaney-Koen, Kelly J. Clark, John J. Dreyzehner, Robert DuPont, Geoffrey Laredo and Carla S. Saunders.
Conference Learning Objectives
- Recognize the need to take a comprehensive, multifaceted and multidisciplinary approach to address the opioid crisis.
- Explain how to partner with faith communities to strengthen the community’s response to the opioid epidemic.
- Identify state policies that could be implemented immediately to prevent overdoses and addiction-related fatalities.
- Identify how to effectively implement the CDC Guideline for Prescribing Opioids for Chronic Pain strategies in clinical settings.
- Describe the role of heroin, fentanyl and synthetic opioids in the U.S. overdose epidemic.
- Define strategies to build and strengthen health/safety partnerships within participants' jurisdictions.
- Describe the current treatment landscape of opioid addiction in the correctional system and identify the challenges and opportunities in implementing best practices in this setting.
- Outline policies around PDMP use and other mechanisms being used to manage risk and diversion and support appropriate medication use.
- Overview data available for fatal opioid overdoses and associated risk factors and its use in informing prevention and response recommendations.
- Explain harm reduction approaches that can be implemented in community pharmacy settings, as well as mechanisms for collaboration between pharmacists and prescribers in providing chronic pain management and medication assisted treatment services.
- Provide a platform to cultivate critical thought and dialogue among those who care for pregnant women with opioid use disorder.
- Explain resources and tools that can empower families to take action to engage loved ones in treatment.
- Identify sustained recovery as the principal goal of addiction treatment.
- Identify best practices for comprehensively reducing Rx misuse and abuse at the community level.
- Describe health plan programs and strategies to address the opioid epidemic.
- Recognize the critical benefits needed for evidence-based addiction treatment and identify where coverage gaps typically occur.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
For complete disclosures, please see individual session slides or click here to view the Disclosures of Conflicts of Interest list.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact Abbegayle Morrow prior to the live event at email@example.com.